Literature DB >> 21782121

Ductal carcinoma in situ: detection, diagnosis, and characterization with magnetic resonance imaging.

Sanaz A Jansen1.   

Abstract

Ductal carcinoma in situ (DCIS) is a preinvasive malignancy that currently accounts for over 20% of newly diagnosed breast cancers in the US. This article reviews how clinical magnetic resonance imaging methods are being implemented for the detection, diagnosis and characterization of DCIS. Research strategies that are being pursued to help realize the full potential for magnetic resonance imaging to improve the outcomes of patients diagnosed with DCIS are discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21782121     DOI： 10.1053/j.sult.2011.02.007

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN： 0887-2171            Impact factor:   1.875


  4 in total

1.  Tumor size estimation of the breast cancer molecular subtypes using imaging techniques.

Authors:  Gulten Sezgın; Melda Apaydın; Demet Etıt; Murat Kemal Atahan
Journal:  Med Pharm Rep       Date:  2020-07-22

Review 2.  AI-Enhanced Diagnosis of Challenging Lesions in Breast MRI: A Methodology and Application Primer.

Authors:  Anke Meyer-Base; Lia Morra; Amirhessam Tahmassebi; Marc Lobbes; Uwe Meyer-Base; Katja Pinker
Journal:  J Magn Reson Imaging       Date:  2020-08-30       Impact factor: 4.813

3.  Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital.

Authors:  Rafael da Silva Sá; Angela Flávia Logullo; Simone Elias; Gil Facina; Vanessa Monteiro Sanvido; Afonso Celso Pinto Nazário
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-06-21

4.  Annual Trends in Ultrasonography-Guided 14-Gauge Core Needle Biopsy for Breast Lesions.

Authors:  Inha Jung; Kyunghwa Han; Min Jung Kim; Hee Jung Moon; Jung Hyun Yoon; Vivian Youngjean Park; Eun Kyung Kim
Journal:  Korean J Radiol       Date:  2020-03       Impact factor: 3.500
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.